Ignite Creation Date:
2025-12-24 @ 1:16 PM
Ignite Modification Date:
2026-01-06 @ 7:09 PM
Study NCT ID:
NCT04625595
Status:
COMPLETED
Last Update Posted:
2021-08-25
First Post:
2020-10-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes
Sponsor:
Immunomolecular Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-09
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-31
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-20
First Submit QC Date:
None
Study First Post Date:
2020-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-24
Last Update Post Date:
2021-08-25
Last Update Post Date Type:
ACTUAL